The U.S. Election Cannabis Playbook Part 1

Breaking down the future of cannabis legalization depending on how Americans vote in the 2020 elections.

Read More»

Aphria 1Q 2021 Earnings – Prices in Freefall

Aphria is putting up the best results in Canada but when compared against US peers, investors need to be looking elsewhere. Opportunity cost matters.

Read More»

Does Pure Sunfarms Make Village Farms a Buy?

Now that Village Farms is the low cost greenhouse leader, is now the time to go all-in?

Read More»
WITH CHRISTOPHER WOOD
DEL0 20081103 NEW DELHI, INDIA : Christopher Wood of CLSA, at the CLSA 2008 India Forum in New Delhi, India on Monday, 03 November, 2008.

Internationally renowned for his salient predictions of market bubbles, Chris provides global investment insights in his weekly column 'Macro Battleship'.

What 3 Things Will Cause the DoorDash IPO to Fail?

DoorDash is built on three pillars. The driver, the restaurant and the customer. Is each pillar sustainable?

Read More»

Asana Stock Guide – Collaboration Disruptor or Just Another Free Trial?

Your guide to investing in Asana. The business, the financials and most importantly, whats it worth?

Read More»

Judging Palantir Stock: AI Mirage or Government-Backed Unicorn?

Everything you need to know to make an educated investment in Palantir. What is the stock worth in 2020 and more importantly in 2030.

Read More»
mj - marijuana oil capsules

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 25th, 2020)

A weekly review of only the most important cannabis news to impact your portfolio

Read More»

Organigram Announces $49M At-The-Market Equity Program

As we feared and warned investors about earlier, the company has announced today that it is doing a at-the-market equity raise program valued at $49M.

Read More»
Marijuana stocks - mj stocks 3

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 18th, 2020)

A weekly review of only the most important cannabis news to impact your portfolio

Read More»

Markets & COVID-19: Dave Collum – Prof. of Organic Chemistry at Cornell

Grizzle interviews Dave Collum, Prof. of Organic Chemistry at Cornell; an engaging chat about markets, gold, covid-19 and all points between.

Read More»

Is Peloton Stock a Buy After Crushing Q4 Earnings?

Are investor’s getting a deal with Peloton or are good times already priced in?

Read More»

Gold Standing Strong Through Market Volatility, Bitcoin is the Catch-Up Trade

Through the recent market sell-off gold has stood strong, retaining it’s role as a safe haven asset. Bitcoin however has sold off, we believe there’s an opportunity for a catch up trade.

Read More»

PSYCHEDELICS

Why Compass Pathways (CMPS) is a 5-bagger: $210/share

Grizzle outlines the structural share price upside of Compass Pathways and its psilocybin drug: COMP 360 to treat depression.

Read More»

The Most Anticipated Psychedelic IPO: Compass Pathways (CMPS)

Grizzle sits down with Terry Chong (Partner, Grizzle Venture) to discuss one of the most anticipated psychedelic IPOs: Compass Pathaways

Read More»

Psychedelics: Interview with MindMed (MMED) CEO JR Rahn

Read More»

AS FEATURED ON

logos logos-mobile